Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000930413-18-003129)

Filing Details

Accession Number:: 0000930413-18-003129
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-10-22 09:00:22
Reporting Period:: 2018-10-18

Accepted Time:: 2018-10-22 09:00:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
316253	Enzo Biochem Inc	ENZ	Services-Medical Laboratories (8071)	132866202

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1694674	A. Bruce Hanna	C/O Enzo Biochem Inc. 527 Madison Avenue New York NY 10022		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-10-18	15,000	$3.52	37,816	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

On January 5, 2017, the Reporting Person was granted 41,632 Stock Options (to acquire common stock), half of which (20,816) vested on January 6, 2018.